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ABSTRACT 
A randomized study of prevalence of primary open  angle  glaucoma  in  
patients  aged  40 and above  attending  Ophthalmology  outpatient  
department in a tertiary hospital 
Aims and Objectives 
To  study  the  prevalence  of  primary  open  angle  glaucoma  in  
patients  aged  40  and above  attending  Ophthalmology  outpatient  department 
in   Tirunelveli Medical College Hospital and     to evaluate their 
awareness and knowledge about glaucoma . 
Materials and methods 
 One hundred patients aged 40 years and above attending Ophthalmology  
outpatient  department in Tirunelveli Medical College  Hospital        from 
January       2012 to   September 2013     underwent complete ophthalmic 
examination. 
Results  
The overall prevalence of primary open angle glaucoma was 5% and the 
prevalence of glaucoma suspect was 1% . Diabetes and hypertension did not 
have any significant etiological association with primary open angle glaucoma. 
The mean IOP in the right eye was 14.22 + 3.37 mm Hg with applanation 
tonometer, 14.50 +3.38 mm Hg with non contact tonometer and 15.41+ 3.19 
mm Hg with Schiotz tonometer. The mean IOP in the left eye was 13.87 +3.35 
mm Hg with applanation tonometer, 14.45 +3.56 mm Hg with non contact 
tonometer and 15.22+ 3.18 mm Hg with Schiotz. IOP found with  applanation 
tonometer  was comparable with non contact tonometer in the right eye (p 
0.133)  but there was a significant difference between them in the left eye  ( p 
0.001).There was a significant difference between applanation tonometer  and 
Schiotz in both eyes (p<0.001). Visual field changes had good correlation with 
the optic disc changes. Cup disc  ratio and peripapillary atrophy had good  
correlation with primary open angle glaucoma. The mean cup disc  ratio in the 
right eye was 0.31 in non glaucomatous and 0.64 in the primary open angle 
glaucoma patients. The mean cup disc  ratio in the left eye was 0.32 in non 
glaucomatous patients and 0.62 in the primary open angle glaucoma patients. 
60% of the primary open angle glaucoma patients were diagnosed newly. 
Glaucoma awareness was extremely low (8%) and  knowledge  was 0%. There 
was no significant association between literacy and glaucoma awareness. 
Previous eye check up and eye camps were not effective in creating awareness 
in the patients. 
Conclusion 
The overall prevalence of primary open angle glaucoma was 5% and the 
prevalence of glaucoma suspect was 1%. Fundus examination to rule out 
glaucoma is mandatory in all patients above 40 years of age. Glaucoma 
awareness (8%) and knowledge (0%) was extremely low considering the 
magnitude of blindness due to glaucoma. Steps to promote awareness among 
the public and health care personnel must be initiated. 
 LIST OF ABBREVIATIONS USED 
POAG   primary open angle glaucoma 
IOP   intraocular pressure 
BP   blood pressure 
RNFL  retinal nerve fibre layer 
ONH   optic nerve head 
GAT   Goldmann applanation tonometer 
NCT   non- contact tonometer 
HFA   Humphrey Field Analyzer 
TOP   tendency- oriented perimeter 
NTG   normal tension glaucoma 
e.g   example 
WGA   World Glaucoma Association 
WGPA  World Glaucoma Patient Association 
APEDS  Andhra Pradesh Eye Disease Study 
ACES  Aravind Comprehensive Eye Survey 
CGS   Chennai Glaucoma Study 
VES   Vellore Eye study 
WBGS  West Bengal Glaucoma Study 
CDR   cup disc ratio 
PPA   peripapillary atrophy  
ABBREVIATIONS USED  IN RESULTS  
RE   right eye 
LE   left eye 
M   male 
F   female 
S   Schiotz 
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    INTRODUCTION 
 Glaucoma is considered the “silent killer of sight”. Until the advanced 
stage, it is asymptomatic. Glaucoma  is an irreversible condition hence early 
detection and treatment is essential for the control of blindness due to 
glaucoma. 
 The case detection rates must be increased by increasing the 
awareness about glaucoma, thereby reducing blindness due to glaucoma. 
Early detection of glaucoma through ‘opportunistic case detection’ by 
performing a comprehensive eye examination at all levels and all available 
instances, and appropriate referral or  initiating treatment as early as possible 
will help to improve the patient’s quality of life. 
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EPIDEMIOLOGY  
Prevalence 
 The prevalence of primary open angle glaucoma ( POAG ) varies 
between various ethnic groups and races. The prevalence is lower in Whites 
(1.3%) when compared to the blacks (4.7%). Singapore Chinese 2.4%, 
Japanese 2.6%, Indians 1.7% but Alaskan Inuits (0.1%) and Mongols (0.5%) 
have lower rates of  prevalence. In Ghana,1 the prevalence is 8% in persons 
aged above 40. 
 Age has more significant influence on POAG than race or ethnicity. 
Before 40 years of age, POAG is uncommon. Prevalence was seen to 
increase from 0.6% (40-49 years) to 7.33% in those above 80 years. 
Incidence 
 The 4 year incidence was found to be 2.2%2. It was found to be age 
dependent – 1.2% in 40 to 49 years to 4.2 % in those aged above 70 years. 
Studies from Framington, Rotterrdom, Australia and Minnesota have 
reported similar age dependent incidence rate of POAG. 
NATURAL HISTORY OF POAG 
 It can be divided into 3 phases– latency phase, detectable preclinical 
phase and clinical phase. 
 The latency phase begins with the onset of glaucomatous optic nerve 
damage and extends up to the detection threshold. 
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 The detectable preclinical phase begins from the lengthy 
asymptomatic phase during which glaucoma is detectable until glaucomatous 
optic nerve damage that leads to symptoms. The detection threshold for 
glaucoma is the point at which glaucomatous optic nerve damage can be 
detected accurately by diagnostic testing. 
 The clinical phase begins with the onset of symptoms. 
   
 Using a “ rule of tens ”, we can roughly approximate the distribution 
of a White or Black population into categories of POAG. For every 1000 
persons aged 40 years and older, 100 are suspected of having POAG on the 
basis of field,  disc, IOP findings or dense risk factors; 10 have POAG and 1 
will be blind due to POAG.   
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CLINICAL RISK FACTORS  
 Identification of risk factors may lead to early intervention and disease 
prevention strategies. Characteristics that affect risk of glaucoma may also 
predict the role of progression of disease. 
GENERAL  
1. Age 
 The prevalence rates doubles for each decade over 40 years (relative 
risk of 2 for each decade ) and is about 10 fold high in above 80 age group 
compared to the 40 to 49 age group. The proportion of individual with optic 
nerve damage and visual loss increases from 1% in persons less than 40 
years to 3 to 8 times higher in individuals above 70 years of age. 3 
2. Race 
 The prevalence is highest in the Blacks4, intermediate in  Whites, 
Hispanics and South Asian population and lowest in North Asian population. 
3. Family history 
 Increased risk of POAG in having a first degree relative with 
glaucoma.5  Around 10–20 % of glaucoma patients have a family history. 
The association is stronger when the affected relative is sibling rather than a 
parent or child. 
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4. Diabetes 
 Diabetes commonly affects the vascular tissues. But the neuronal and 
glial tissues in the retina are also compromised leading to apoptosis of the 
retinal ganglion cells. The  neurons and the glia that are already under a 
compromised state due to diabetes becomes easily susceptible to the  added 
on stress such as elevated intraocular pressure caused by POAG.6  
 When compared to the general population, diabetes have a higher 
prevalence of POAG and ocular hypertension. 
 The prevalence of diabetes or a positive glucose tolerance test has also 
been shown to be higher in patients with POAG and steroid responders. 
 Diabetes also appears to influence the nature of visual field loss in 
patients with POAG, with a prevalence of inferior field loss of 64.4% versus 
36.4% in diabetics versus non-diabetics, respectively, and a 32% prevalence 
of diabetes among POAG patients with primarily inferior loss, compared to 
13% in those without such a defect.7  
5. Systemic hypertension 
 Individuals with systolic blood pressure above a threshold of 130 
mmHg had a higher prevalence of open angle glaucoma compared with those 
with lower systolic blood pressure. Nocturnal arterial hypotension is more 
common in normal tension glaucoma than in primary open angle glaucoma 
with elevated intraocular pressure ( IOP ).8 
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 The optic disc capillary circulation may be more precarious as blood 
pressure ( BP ) increase and that resultant impaired perfusion of the optic 
disc may play a contributory role in producing glaucoma. 
6. Migraine and Vasospasm 
 Migraine which may be associated with transient alterations of ocular 
blood flow and peripheral vasospasm have been suggested as risk factors for 
open angle glaucoma. This is more closely associated with normotensive 
glaucoma.9 
OCULAR 
1.Intraocular pressure 
 It is both a risk factor and cause of glaucoma. Reducing IOP by an 
average of 23% decreased the incidence of POAG by 60%.10 Greater 
pressure lowering results in less progression and stable visual fields.11 
2.Optic nerve head and peripapillary features 
 Disc haemorrhages have an elevated risk for progressive visual field 
loss. It is associated with normal tension glaucoma.12 
 Peripapillary atrophy correlates with the presence of glaucoma but not 
specific for it. Peripapillary atrophy may worsen along with glaucoma 
progression. Zone beta atrophy is more common with POAG. 
3. Myopia 
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 Myopia is a risk factor for glaucoma with higher prevalence in 
myopes exceeding 6 dioptres.13 
4.Others  
 Thin corneal thickness14 and exfoliation syndrome are more associated 
with increased risk for progression. 
CLASSIFICATION OF GLAUCOMAS 
Glaucomas is classified15 based on : 
The etiology  (i.e the underlying  pathology that causes alteration of aqueous 
humour dynamics) 
 -Primary ( no obvious systemic or other ocular disorders ) 
 -Secondary (associated with ocular or systemic abnormalities) 
The mechanism ( i.e increase in IOP caused by alteration in the anterior 
chamber angle) 
 -Open angle glaucoma 
 -Angle closure glaucoma 
CLASSIFICATION OF GLAUCOMAS BASED ON MECHANISM 
OPEN ANGLE GLAUCOMA 
1) Pretrabecular ( membrane overgrowth) 
 a) Fibrovascular membrane (neovascular glaucoma) 
 b) Endothelial layer with descemet membrane like membrane 
  - Iridocorneal endothelial syndrome 
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  - Posterior polymorphous dystrophy 
  - Penetrating and non penetrating trauma 
 c) Epithelial downgrowth 
 d) Fibrous ingrowth 
 e) Inflammatory membrane 
  - Fuch’s heterochromic iridocylitis 
  - Luetic interstitial keratitis 
2) Trabecular form 
 a) Idiopathic 
  - Chronic open angle glaucomas 
  - Steroid-induced glaucomas 
 b) Clogging of the trabecular meshwork 
  - Red blood cells 
   Hemorrhagic glaucoma 
   Ghost cell glaucoma 
  -Macrophages 
   Hemolytic glaucoma 
   Phacolytic glaucoma 
   Melanomalytic glaucoma 
  - Neoplastic cells  
   Malignant tumours 
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   Neurofibromatosis 
   Nevus of Ota 
   Juvenile xanthogranuloma 
  -Pigment particles 
   Pigmentary glaucoma 
   Exfoliation Syndrome 
   Uveitis 
   Malignant melanoma 
  -Protein 
   Uveitis 
   Lens-induced glaucoma 
   Viscoelastic agents / postoperative 
   Silicone oil 
   Alpha-chymotrypsin induced glaucoma 
   Vitreous 
 c) Alterations in the trabecular meshwork 
  - Edema 
   Uveitis (Trabeculitis) 
   Scleritis and episcleritis 
   Alkali burns 
  - Trauma (angle recession) 
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  - Intraocular foreign bodies ( Hemosiderosis, Chalcosis) 
3) Posttrabecular form 
 a) Obstruction of Schlemm  canal 
  - Collapse of canal 
  - Clogging of canal (e.g. Sickled RBCs) 
 b) Elevated episcleral venous pressure 
  - Carotid -cavernous fistula 
  - Cavernous sinus thrombosis 
  - Retrobulbar tumours 
  - Thyrotropic exophthalmos 
  - Superior vena cava obstruction 
  - Mediastinal tumours 
  - Sturge-Weber Syndrome 
  - Episcleral venous pressure elevation 
ANGLE CLOSURE GLAUCOMA 
1) Anterior forms (“Pulling” mechanism) 
 a) Contracture of membranes 
  Neovascular glaucoma 
  Iridocorneal endothelial syndrome 
  Posterior polymorphous dystrophy 
  Penetrating and non penetrating trauma 
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 b) Contracture of inflammatory precipitates 
2) Posterior (“Pushing” mechanism) 
 a)  With pupillary block 
  - Pupillary block glaucoma  
  - Lens induced mechanism 
   Intumescent lens 
   Subluxation of lens 
   Mobile lens Syndrome 
  -Posterior synechiae 
   Iris-vitreous block in aphakia 
   Iris-intraocular lens block in pseudophakia 
   Uveitis with posterior synechiae 
 b) Without pupillary block 
  - Plateau Iris Syndrome 
  - Ciliary block (Malignant) glaucoma 
  - Lens induced mechanisms 
   Intumescent lens 
   Subluxation of lens 
   Mobile lens syndrome 
  - Following lens extraction (forward vitreous shift) 
  - Following scleral buckling 
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  - Following pan retinal photocoagulation 
  - Central retinal vein occlusion 
  - Intraocular tumours 
   Malignant Melanoma 
   Retinoblastoma 
  - Cysts of the iris and ciliary body 
  - Retrolenticular tissue contracture 
  - Retinopathy of prematurity 
  - Persistent hyperplastic primary vitreous 
DEVELOPMENTAL ANOMALIES OF THE ANTERIOR CHAMBER 
ANGLE 
1) High insertion of anterior uvea 
 Congenital (infantile) glaucoma 
 Juvenile glaucoma 
2) Incomplete development of trabecular meshwork/ Schlemm  canal 
  Axenfeld -Rieger syndrome 
 Peter’s anomaly 
 Glaucomas associated with other developmental anomalies 
3) Iridocorneal adhesions 
 Broad strands (Axenfeld- Rieger Syndrome) 
 Fine strands which contract to close angle ( aniridia ) 
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PRIMARY OPEN ANGLE GLAUCOMA 
 It is also known as chronic open angle glaucoma and chronic simple 
glaucoma. It is the commonest form of glaucoma accounting for atleast half 
of all the glaucomas. 
 At least two of the three criteria in the presence of a normal open angle 
glaucoma confirmed by gonioscopy: 16  
1) An intraocular pressure above 21mm Hg on more than one occasion, 
asymmetry of IOP of more than 5 mm Hg between the two eyes and a 
circadian variation in IOP more than 8mm Hg 
2) Optic nerve head changes suggestive of glaucomatous damage 
3) Typical glaucomatous visual field 
A. PATHOGENESIS 
 A sustained increase in IOP may be due to difficulty in its exit. 
Increased IOP is mainly due to increased resistance to the circulation of the 
aqueous at the pupil and /or to its drainage through the angle of the anterior 
chamber. Uveoscleral outflow accounts for 20% which is insufficient to 
maintain normal IOP.  
1) CHANGES IN TRABECULAR MESHWORK17 
I) Foreign materials such as glycosaminoglycans, amorphous material, 
extracellular lysosomes, plaque-like materials and proteins causing 
obstruction of the trabecular meshwork. 
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II)  The functions of trabecular endothelial cells such as phagocytosis and 
synthesis and degradation of macromolecules is interfered. 
III) Giant vacuoles present in the inner wall of endothelium of Schlemm’s 
canal is lost. These vacuoles provide a pathway for drainage of fluid from 
meshwork into the Schlemm’s canal. 
IV) The endothelial cells are underactive or  overwhelmed by foreign 
material, leading to cell death and loss of normal phagocytic activity, that is, 
the self-clearing filter property of the meshwork.  
V) Decreased permeability of trabecular meshwork due to 
 a) Increased sensitivity to adrenergic agonists 
 b) Increased levels of gamma-globulin and plasma cells in trabecular  
 meshwork and increased antinuclear antibodies 
 c) Altered corticosteroid metabolism 
  - Elevated plasma levels of cortisol 
  - Increased suppression of plasma cortisol with different doses    
  of  exogenous  dexamethasone 
  - Disturbed pituitary adrenal function  
  -  Increased inhibition of mitogen stimulated lymphocyte     
  transformation by glucocorticoids. 
  Myocilin (TIGR-trabecular meshwork-inducible glucocorticoid 
response ) gene governs the steroid responsiveness in  POAG patients.18 
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2) CHANGES IN OPTIC NERVE HEAD 
The local characteristics of the nerve head that play a role in  resistance 
against increased IOP - 
 Diameter of scleral ring 
 Strength of lamina cribrosa 
 Integrity of vascular supply 
Vasogenic theory of nerve damage 19 
 This theory implies that structural and functional defects occurring in 
optic nerve head with glaucoma are due to ischemia. 
Increased IOP leads to reduced capillary blood flow due to 
a)Mechanical compression of vessels at lamina cribrosa 
b)Reduced flow in annulus of Zinn which supplies nutrition to laminar 
and post laminar optic nerve head  
 Recently, Anderson put forth the hypothesis that inhibition of 
autoregulation of blood supply to optic nerve can cause increased 
susceptibility of disc to pressure induced ischemia.20 
Mechanical theory of nerve damage 
 Lamina cribrosa cannot withstand high intraocular pressure. The nerve 
fibres are supported by glial tissue and have to bend over the edge of the disc.  
 Increased IOP leads to mechanical pressure on lamina cribrosa, 
altering capillary blood flow and reduced axoplasmic flow in the initial 
16 
 
stages. Later, significant backward displacement and compaction of the 
laminar plates narrows the openings through which the axons pass, directly 
damaging the nerve fibre bundles, leading to atrophy. 
Biochemical theory 
 Decrease in neurotropic factors / increased levels of neurotoxins. 
Genetics 
 25 loci have been linked with POAG but only three genes have been 
identified –Myocilin, 21 Optineurin and WDR36. 
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B. CLINICAL FEATURES 
Symptoms 
 POAG has an insidious onset, slowly progressive, bilateral condition 
usually asymptomatic until the advanced stages of the disease. Rarely the 
patient may notice a scotoma when performing a monocular visual task or 
may have frequent change of glasses. As glaucoma advances, they may 
become symptomatic from loss of fixation in one or both eyes or loss of 
peripheral vision to tubular vision, which interferes with activities such as 
driving. 
Signs 
1)  Elevated IOP 
 Elevated IOP  may range from 22 to 40 mmHg , occasionally may 
reach 60 or 80 mm Hg. 
 Normal diurnal fluctuation is less than 5 mm Hg while more than 8 
mm Hg is abnormal. IOP is maximum in the early morning and minimum in 
the night. 
 Diurnal intraocular pressure measurements is useful in diagnosing 
POAG, explaining progressive damage inspite of apparent adequate IOP 
control. It helps in evaluating the efficacy of therapy and distinguishing 
normal tension glaucoma from POAG.22 
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Tonometer 
 Tonometer is the instrument used to measure the intraocular pressure 
by relating a deformation of the globe to the force responsible for the 
deformation. The two basic types of tonometers differ according to the shape 
of the deformation: indentation and applanation (flattening). 
1.Applanation instruments 
Variable force 
 The force required to flatten a standard area of the cornea is measured . 
The prototype in this group is the Goldmann applanation tonometer. 
 - Goldmann applanation tonometer ( GAT ), Perkins tonometer, 
Draeger tonometer, Mackay – Marg and Tono – pen  tonometers, Pneumatic 
tonometer, Non- contact tonometer ( NCT ) / Ocular Response Analyzer and 
Ocuton tonometer 
Variable area 
 The area of the cornea flattened by a known weight is measured.  
 - Maklakov tonometer is the prototype. 
2.Indentation instruments  
 The shape of deformation is the truncated cone. Conversion tables 
must be used to measure the IOP. 
Schiotz tonometer and Impact rebound tonometer.  
The Schiotz tonometer is the prototype. 
19 
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2) Optic disc changes 
 As bundles of axons are destroyed in an eye with glaucoma, the neural 
rim begins to thin in one of the several patterns. 
a) Focal atrophy –The vertical cup-disc ratio becomes more than the 
horizontal cup disc ratio. The changes in chronological order are : 
 a. Polar notching (focal notching or pit like change (pseudopit) - 
usually in the inferior temporal quadrant, sharpened polar neural edge, 
sharpened rim  and notching upto the disc margin. 
 b.Bayonetting sign - Sharp bend of the retinal vessels at the disc edge 
in the areas of sharpened rim. 
b) Concentric atrophy 
 Enlargement of the cup in concentric circles, most often directed 
inferotemporally or superotemporally. 
 Temporal unfolding – the loss of neural rim tissue begins temporally 
and then progresses circumferentially toward the poles.24 
 The thinned out neural rim is seen as cresentic shadow adjacent to the 
disc margin . 
c) Deepening of the cup 
 leads to overpass cupping and exposure of underlying lamina cribrosa. 
(Laminar dot sign ) 
d) Pallor/Cup discrepancy 
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 Cupping greater than pallor indicates glaucomatous optic atrophy and 
pallor greater than cupping indicates non-glaucomatous optic atrophy. 
e) Advanced glaucomatous cupping – loss of all neural tissue. 
 Bean-pot cupping – white disc with total loss of neural rim tissue and 
the vessels bend at the margin of the disc.25 
Vascular signs 
1) Optic disc haemorrhages26 
 - Splinter haemorrhages near the margin of the optic disc  
 - common location is in the inferior quadrant 
 - may be the first sign of glaucomatous damage preceding retinal   
 nerve fibre layer defects, notches in the neural rim and field defects 
2) Tortuosity of retinal vessels 
 is seen in advanced glaucomatous optic atrophy 
3) Location of retinal vessels in relation to the cup 
 - Overpass cupping  
 - Baring of the circumlinear vessels  
4) Nasal displacement of the retinal vessels does not provide a useful 
diagnostic parameter. 
Peripapillary changes  
 Peripapillary atrophy consists of two zones – inner zone beta which is 
a depigmented chorio scleral crescent and outer zone alpha with increased 
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pigmentation. Zone beta is more associated with glaucoma and progressively 
increases in size with progression of glaucoma.27 
Nerve fibre bundle defects 
  Appear as dark stripes or wedge shaped defects or diffuse loss of 
striations. The diffuse loss is more common in glaucoma patients than in 
ocular hypertensives. 28 
3) Gonioscopy 
- This is performed using an indirect goniolens of either the Goldmann or 
Zeiss 4 mirror type.  
- In POAG, anterior chamber angle is open. 
- Have more iris processes, higher insertion of the iris root, more trabecular 
meshwork pigmentation 29 and a greater than normal degree of segmentation 
in the pigmentation of the meshwork. 
4) Visual field abnormalities 
 It is initially observed in Bjerrum area, 10-250 from fixation. Later, it 
ranges from paracentral scotomas, nasal step, Seidel scotoma,  arcuate or 
Bjerrum scotoma, ring scotoma or double arucate scotoma, tubular vision to 
end-stage or near total defect, with only a residual temporal island of vision. 
 The nonspecific changes are generalised depression of visual field, 
concentric contraction of the visual field which is more marked in the nasal 
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field called “crowding of the peripheral nasal isoptres”, enlargement of the 
blind spot and angioscotoma. 
 Progressive visual field loss is the most useful guide for diagnosis, 
treatment and follow up in POAG. 30 
C.DIAGNOSIS 
A diagnosis of POAG can be made after performing the following tests: 
1.   Intraocular pressure recording 
2.   Optic nerve head / retinal nerve fibre layer (RNFL)  assessment 
3.   Gonioscopy 
4.   Visual field analysis 
Optic Nerve Head Assessment is done using 
 - Slitlamp and an auxiliary fundus lens ( Goldmann 3 mirror contact 
lens, the handheld 78 D or 90D lens, Hruby lens slitlamp attachment ) 
 - A diagrammatic representation of the disc, neuroretinal rim, vascular 
alterations and nerve layer defects at every follow-up 
 - Stereo photography of the optic nerve head ( ONH ) -to ascertain 
small changes sequentially 
Analysis of Optic nerve head and Retinal nerve fibre layer is done using 
 - Direct ophthalmoscope with a red-free filter (ophthalmoscopy) 
 - Slitlamp and an auxiliary fundus lens with a red-free filter 
24 
 
 - Glaucoma diagnosis ( GDx ) RNFL analyzer uses the principle of 
Confocal Scanning Laser Polarimetry. It is used to measure the peripapillary 
RNFL thickness. 
 - Optical Coherence Tomography provides high resolution cross-
sectional imaging of the ONH , RNFL and macula. It gives the best axial 
resolution. The macular imaging programme detects early glaucomatous 
changes. 
 - Heidelberg Retina Tomography uses the principle of confocal 
scanning laser ophthalmoscopy. It is used to obtain three-dimensional images 
of optic disc to detect glaucomatous damage and to assess progression in 
glaucoma. 
Perimetry 
 Perimetry is the technique employed to examine and quantify the 
visual field using targets of various sizes and colours.  
It is of two types  
 1)  Kinetic  
 2)  Static 
Static techniques 
 Automated ( Humphrey Field Analyzers HFA , Octopus  ) and manual 
(Goldmann perimetry ) are examples of static techniques. It is the preferred 
method of testing field which uses various testing strategies.31 
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Kinetic techniques 
 Confrontation, Tangent screen , Lister perimeter and Goldmann 
perimeter are the examples of kinetic perimetry in which the intensity and 
size of the stimulus is kept constant but the stimulus location is moved (non-
seeing to a seeing area ). 
Newer perimetric techniques 
1) Short-wavelength automated perimetry (SWAP ) 
 -blue on yellow perimetry  
 -helps in early identification of glaucomatous damage by testing 
 small ganglion cells, called bistratified blue-yellow ganglion cells -
 available on HFA II (700 series) and Octopus 1-2-332 
2) Frequency – doubling technology (FDT ) perimetry 
 - Low spatial frequency sinusoidal grating undergoing rapid phase -
 reversal flicker 
 - Preferentially activate M cells early identification of glaucomatous 
 damage33   
 - older instrument using 16 to 18 large test fields.  
 - screening programmes 
 - new instrument Matrix with 54 smaller test fields 
3) HRP – High Pass Resolution Perimetry, also known as ring perimetry 
4) Flicker perimetry in the Octopus perimeter 
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For assessing possible progression 
 Delta program with the Octopus perimeter  
 Humphrey Field Analyzer 
  - STATPAC 2 ( includes linear regression analysis and   
  glaucoma change probability) 
  - Progressor Program for analysis of serial fields 
  - Glaucoma Change Probability (GCP ) 
  - Glaucoma Probability Analysis ( GPA ) 
D.MANAGEMENT 
 IOP is the only modifiable risk factor in POAG. Hence all treatment 
modalities target the IOP. Lowering IOP is associated with significant 
lowering of glaucoma progression34. 
Steps towards efficient treatment of POAG includes –  
 1.Assessment of glaucomatous damage 35 
 Disc Visual field 
Mild 
0.0 – 0.5 with uniform 
pink rim 
None, mild depression, or slight 
defect 
Moderate 
0.6-0.7 with some local 
narrowing of rim 
General depression, arcuate defect,or 
paracentral scotoma 
Advanced 
0.8- 0.9 with rim 
narrowing or notching 
Large arcuate, double arcuate, 
hemifield loss, or fixation threatened 
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2.Fix target IOP  
Target IOP 
 It is defined as “ A range of acceptable IOP levels within which the 
progression of glaucomatous neuropathy will be halted / retarded .”36   
  Lower target IOP set if lower the initial IOP, older age, more 
advanced glaucomatous damage presence of cardiovascular disease or 
diabetes, the risk of central retinal vein occlusion, as well as individuals who 
are one- eyed or in whom visual fields or disc evaluation is not possible. 
 
 
TARGET IOP 
%  IOP  reduction IOP set below (mm Hg ) 
Mild 20 18 
Moderate 30 15 
Advanced 50 13 
 
3.Medical / laser / surgery to achieve target IOP 
4.Follow up to look for progression of glaucomatous damage 
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1) Medical therapy 
  The basic principle of medical therapy is 
- to use the least amount of medicine that will control the glaucoma with the 
fewest side effects. 
- to treat only one eye initially in symmetric cases, so the fellow eye can be 
used as a control in determining the efficacy of therapy.  
Medical 
a) Topical, β-
Blockers 
b) Carbonic-
anhydrase 
inhibitor 
c) Prostaglandin 
analogue 
d) α- agonist 
e) cholinergic 
agonist 
 
a) Argon Laser 
trabeculoplasty 
b) Selective laser 
trabeculoplasty 
a) Trabeculectomy 
b) Viscocanalostomy 
c) Artificial drainage 
valves.  
 Eg : Ahmed 
Glaucoma Valve, 
 Molteno Implant  
Laser Surgery  
TREATMENT FOR POAG 
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Neuroprotective agents 
 These include anecortave, cannabinoids, cellular cytoskeletal 
modulators (ethacrynic acid latrunculins), olmesartan, lomerizine, 
neurotropins, memantine, nitric oxide, prostanoid agents and rho kinase 
inhibitors. 
2) Laser 
 The Glaucoma Laser Trial37 provided some support for laser 
trabeculoplasty (argon laser) as initial therapy. But, mostly it is used as an 
adjunct to medical therapy. Argon, diode, or selective laser energy (selective 
laser trabeculoplasty) is applied to the surface of the trabecular meshwork to 
increase the aqueous outflow.38 
3) Surgical intervention 
Indications  
a. Patients who are poor candidates for conventional medical treatment 
b. Patients in whom the target IOP is unlikely to be achieved with topical 
medications alone 
c. Further progression of visual field loss likely to affect the patient’s quality 
of life 
d. When rapid IOP lowering to the desired target level is required in patients 
with rapidly progressive glaucomatous optic neuropathy where quality of  life 
would otherwise suffer 
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e. whenever there is progressive glaucomatous damage despite "maximum 
tolerable medical therapy" 
f. Patients with poor drug compliance or drug tolerance 
g. Patients not accessible to an ophthalmologist 
h. Good IOP control with surgery in the fellow eye 
FILTERING SURGERY 
 Opening or fistula at the limbus         direct communication between 
the anterior chamber and the subconjunctival space  aqueous absorbed by 
surrounding tissues or crosses conjunctival epithelium and drained through 
tears. 
 In patients with glaucoma that is refractory to standard filtering 
surgery, aqueous drainage devices can be considered. It is indicated in 
patients with extensive conjunctival scarring, chronic ocular inflammation 
and ocular trauma. Glaucoma drainage devices are not as effective as filtering 
surgery in controlling IOP.  
 Cyclophotocoagulation can be considered as the last resort  for the 
patients with refractory glaucomas, those with multiple failed filtering 
procedures and with visual potential is poor.39 
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FISTULIZING 
TECHNIQUES 
NONPENETRATING 
PROCEDURES 
1.Partial thickness 
 Trabeculectomy 
2.Full thickness 
 Sclerectomy 
 Trephination 
 Thermal sclerostomy 
 Iridencleisis 
 
1.Deep sclerectomy 
2.Viscocanalostomy 
GLAUCOMA DRAINAGE 
IMPLANTS 
Open-tube drainage devices 
 -Baerveldt , Molteno, 
Schocket 
Flow-Resticted drainage devices 
 -Ahmed, Krupin 
 
GLAUCOMA SUSPECT 
Open angle by gonioscopy and one of the following in at least one eye40 : 
1) IOP consistently >21 mm Hg by applanation tonometry 
2) Appearance of the optic disc or retinal nerve fibre layer suggestive of 
glaucomatous damage 
3) Diffuse or focal narrowing or sloping of the disc rim 
4) Diffuse or localized abnormalities of the RNFL , especially at superior 
and inferior poles 
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5) Disc haemorrhage 
6) Asymmetric appearance of the disc or rim between fellow eyes, 
suggesting loss of neural tissue 
7) Visual fields suspicious of early glaucomatous damage 
DECISION TO TREAT IN GLAUCOMA SUSPECTS WITH 
ELEVATED IOP 
 The patients are classified into low, moderate, or high risk for 
progression based on the available evidence and clinical judgement 
High risk – Treatment must be initiated 
Moderate risk – Treatment given if required, or monitor closely 
Low risk – Monitor IOP , optic nerve structure and function, and treat if 
progression occurs 
NORMAL TENSION GLAUCOMA 
Normal tension glaucoma (NTG) is a progressive disease 
 - IOP consistently equal or less than 21mm on diurnal testing, with no 
single measurement greater than 24mm Hg and off treatment 
 - Open drainage angles on gonioscopy 
 - Absence of any secondary cause for a glaucomatous optic 
neuropathy 
 - Typical optic disc damage with glaucomatous cupping and loss of 
neuroretinal rim 
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 - Visual field defect compatible with the glaucomatous cupping and 
loss of neuroretinal rim  
 - It is a disease of elderly and is more prevalent in females. OPA 1 
gene is the major genetic marker of NTG41 
Etiology 
 The factors involved in the causation of NTG can be divided into : 
a. Pressure independent factors 
 Abnormal blood flow – Vasospasm as in migraine and Raynaud’s 
phenomenon 
 Nocturnal  hypotension  due  to night  dose  antihypertensives  
 Abnormal blood coagulability and increased blood viscosity 
 Systemic diseases like diabetes mellitus, ischemic heart disease, 
carotid artery atheroma, cerebrovascular accidents 
b. Pressure dependent factors 
 IOP is still a risk factor in the development and progression of the 
disease. 
Characteristic features 
There is increased incidence of  
  - optic disc haemorrhages  
  - peripapillary atrophy 
  - thin neuroretinal rim especially inferiorly and  inferotemporally 
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 - more localised RNFL defects, closer to the macula 
 - field defects tend to be localised, deeper and closer to fixation 
Management 
1. Detect and confirm damage 
 Serial perimetry confirms the existing field defects and detects 
progression. 
2. Rule out high-tension glaucoma 
 This is done by repeated IOP measurements. 
3. Detect / rule out etiological factors and risk factors 
Look for evidence of 
 a)  Vasospastic disorders such as migraine or Raynaud's phenomenon 
 b)  Nocturnal dip in BP in elderly patients, wherever possible by 24 
hours continuous BP monitoring 
 c)  Rule out systemic haemodynamic abnormalities e.g. Myocardial 
dysfunction, hyperlipidaemia, hypertension and diabetes mellitus 
4. Rule out neurological causes of  disc pallor 
 CT scan or MRI of brain  mandatory in the following situations: 
•  In patients who do not show disc/field correlation  (pallor more than 
cupping) 
•  Visual field defects respecting the vertical midline 
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•  In patients who have neurological signs and symptoms other than visual 
loss 
5. Monitoring for deterioration progression 
6. Treatment options 
 The treatment of NTG is directed at preventing further optic disc 
damage by modulating the pressure dependent and pressure independent 
factors. 
•  IOP lowering treatments 
Reduction of IOP by 30% to halt or slow down progression42 
 This can be achieved by topical medications , argon laser 
trabeculoplasty (ALT) or by surgery. 
 - Prostaglandin and prostamide derivatives like latanoprost and 
bimatoprost. 
 - Patients who show progression and in whom the medical treatment 
does not achieve 30% reduction IOP need filtration surgery preferably with 
the use of anti-fibroblastic agents such as mitomycin-C and 5- flurouracil. 
•  Non IOP lowering treatments 
 oral calcium channel – increases ONH capillary perfusion 
Topical betaxolol, brimonidine -neuroprotective agents if progression 
continues despite adequate lowering of IOP. 
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GLAUCOMA AWARENESS 
1) Public  
2) Health care personnel and eye care 
3) Human resource development 
1) PUBLIC 
Talk to your family and friends about glaucoma 
Can visit websites that are exclusive for glaucoma 
Free educational booklets 
 National Eye Health Education Program ( NEHEP ) is a program to 
raise awareness about glaucoma among people at higher risk and their 
friends. Various public service announcements through radio, television and 
print are made in this. 
2.HEALTH CARE PERSONNEL AND EYE CARE 43 
 To increase eye care personnels, ophthalmologists, optometrist, 
equipment technician. National and local training centers must be increased. 
1.Primary 
-Comprises promotive  and preventive actions carried out by the ophthalmic 
assistants. Referral of the cases done at this level. 
- Social and community developments which promote health through 
changes in behaviour and the environment. This is the hardest to be achieved 
but has the greatest impact. 
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- Strengthening family and community cooperation for recognition and 
appropriate care of the glaucoma patients 
- Delivery of eye care 
2.Secondary 
 Carried out at district level which should provide definitive 
management . The main challenge at this level is case detection. Patient with 
possible disease is referred to the tertiary level. If filtering surgery is been 
done the patient must have periodic evaluation with the secondary health 
care worker and should be re-referred when  IOP raises. 
3.Tertiary 
Variety of diagnostic and therapeutic measures  
Training- Trained to perform iridectomies ,  gonioscopy to examine optic 
disc and visual fields. 
Screening- Since entire population cannot be screened the high risk  
population can be focussed on. 
Availability of drugs- Anti glaucoma medications must be available at all 
levels of health care. 
Mobile eye services 
 These fulfil the functioning of delivering primary and secondary eye 
care. These services should be temporary and replaced by permanent 
infrastructure for eye health care. 
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3.HUMAN RESOURCE DEVELOPMENT 
- To increase eye care personnel,  ophthalmologists, optometrists, equipment 
technician. 
- Local and national training centres must be increased. 
CAMPAIGNS FOR GLAUCOMA AWARENESS 
INTERNATIONAL 
 WHO Programme for the Prevention of Blindness and Deafness is to 
provide essential eye care to all populations and to eliminate avoidable 
blindness. 
 World Glaucoma Association (WGA) works to optimize the 
awareness of glaucoma through cooperation among regional and national 
Glaucoma Societies.  
 The World Glaucoma Patient Association ( WGPA )works through 
national Glaucoma Patient Associations. 
 “BIG – Beat Invisible Glaucoma” campaign – the 6th World 
Glaucoma Awareness Week 2014 is to be held on March 9-15, 2014 to raise 
the awareness of glaucoma and the importance of regular eye exams   for 
early detection of glaucoma. During this week, patient and eye care 
professionals around the world participate in the activities to support the 
cause.  
 January is glaucoma awareness month. 
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NATIONAL 
Glaucoma society of India works to -  
 
  
Glaucoma 
Society of 
India
Implement 
surveillance 
and evaluation 
systems
Eliminate 
health 
disparities and 
focus on at –
risk population
Assure 
professional 
workforce 
Address 
behavioural 
changes
Include 
systems and 
policy changes 
Establish an 
applied public 
health research 
agenda
Integrate 
vision health 
interventions 
into existing 
programs
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 - Glaucoma Society of India  
  to create awareness among the public  
  to guide glaucoma patients for the correct treatment. 
 - Glaucoma India Education Program to enlighten the advances in the 
 diagnosis and treatment of glaucoma to as many as Ophthalmologists 
 as possible. 
 - Vision 2020 
Strategies to improve vision health 
 
  
VISION 2020 
What Vision 2020 has done regarding glaucoma 
- Research into various aspects of glaucoma is being conducted 
internationally. 
Assessment
• establishing a surveillance system to collect 
information regarding burden of glaucoma
Application
• to evaluate the cost effectiveness of 
interventions and to increase the access and 
utilization of vision care services
Action
• to develop public health intervention programs 
and to enhance the role of existing organizations
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- New treatment options are evaluated and new anti-glaucoma drugs have 
been on trial. 
- Screening tests for glaucoma have been developed. 
What Vision 2020 is doing regarding glaucoma 
-Training of ophthalmologists, optometrist and mid-level personnel, 
including refractionist. 
-The secondary and tertiary eye care centres are equipped to provide 
essential eye care services for the glaucoma patients. 
- Availability of basic equipment and low cost drugs. 
- Glaucoma screening made a part of regular eye checks especially for 
patients at high risk. 
- Increase public awareness about glaucoma and about the consequences of 
the disease been left undiagnosed. 
- Patient education and counselling for increasing patient drug compliance 
and regular eye checks. 
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   REVIEW OF LITERATURE 
 The prevalence of glaucoma suspects on the basis of elevated IOP in 
persons older than 40 years was 4% to 10% in the studies conducted  by 
Bankes JL, et al.44Rates of ocular hypertension reported in the Andhra 
Pradesh Eye Disease Study (APEDS)45 was 0.42% , 1.1% in the Aravind 
Comprehensive Eye Survey (ACES)46, 3.08% in Vellore Eye study(VES).47 
Primary open angle glaucoma 
 The prevalence of POAG is 0.5 - 1% in persons aged over 40 in the 
studies performed in U.S and Western Europe.48 In the Tajimi study49, 3.9% 
of those over 40 years had POAG with majority of people having IOP less 
than 21mmHg. In pooled analysis of population based studies, prevalence 
was seen to increase from 0.6% (40-49 years) to 1.5% (50 – 59 years), 2.7% 
(60-69 years), 5.1% (70 – 79 years ) and 7.33% in those above 80 years. The 
Los Angeles Latino Eye Study50 found that Latinos in the United States have 
a prevalence of 4.7 % . A hospital based study by Smita et al 51 in Northern 
India showed a high prevalence of POAG (33% ). 
 The VES reported the lowest rates of 0.41%, mainly because the study 
was limited to the age group of 30-60years and low rate of visual field 
performance. 2.56% in APEDS, 1.7% in ACES, 1.62% in Chennai Glaucoma 
Study (CGS) rural, 3.51% in CGS52 urban and 2.99% in West  Bengal 
Glaucoma Study (WBGS).53 
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 Increasing age was a risk factor in all studies. Males were at greater 
risk in the ACES. No such difference was noted by any of the other studies. 
Myopia was a risk factor only in ACES.  
 A positive correlation between glaucoma and diabetes was shown by 
Rotterdam study, Netherlands54 and the Blue Mountains eye study, 
Australia.. The Baltimore eye survey found little evidence of an association 
between glaucoma and either insulin dependent or non-insulin dependent 
diabetes. 
 There was no significant association between hypertension and POAG 
in the study by Tielsch et al55 and Uhm and Shin56. Population based data 
from Framingham study and Baltimore eye survey also failed to find any 
association between BP and POAG. The Rotterdam study reported an 
association of systemic hypertension with high-tension glaucoma. A hospital 
based study by Mohammed et al 57 showed positive correlation between 
POAG and systemic hypertension. 
 65% of those with POAG in APEDS, 45% in ACES, 67% in CGS 
(rural) and 82% in CGS (urban) had normal presenting IOP. This means that 
single normal IOP does not rule out the disease. Optic disc evaluation is 
necessary to identify those with glaucoma. 
  IOP measured with GAT and NCT was compared in a study by Shalini 
Mohan et al. IOP was comparable at lower range but was unreliable in 
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patients with higher IOP  range.58 In a study by Muller et al, there was no 
significant difference between GAT and NCT while indentation tonometer 
showed differences.59 
 The mean vertical cup disc ratio (CDR) was 0.56 in VES done in an 
unselected population60 and 0.39 in CGS. In a study by Krishna et al, the CDR 
and the rim disc ratio was considered to be clinically significant in 
determining abnormal glaucomatous optic discs.61 
 According to Kasner et al, the absence of peripapillary atrophy(PPA) 
is associated with decreased risk of glaucomatous damage in ocular 
hypertensives. 
 The proportion of persons bilaterally blind from POAG was 11% 
(APEDS), 1.6% (ACES), 5.2% in WBGS, 3.2% (CGS rural) and 1.5% (CGS 
urban). 
 The rate of undiagnosed patients was 92.6% in APEDS,  93%  in 
ACES and 98.5% in CGS . 50% of the patients  diagnosed to have POAG in 
ACES had an previous eye examination by the ophthalmologist but <20% of 
them were detected to have glaucoma before the study evaluation. 
 Awareness about glaucoma ranged from 0.27% in the rural population 
Andhra Pradesh ( Krishnaiah et al)62 to 13.3% ( Sathyamangalam et 
al).63According to Dandona et al,64 awareness rate was 2.3%. This is very 
much lower than the rates reported from United States of America (72-81%) 
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and Australia (70-92%). In a hospital based study by Prabhu et al, 4.8% were 
aware of glaucoma. 
 The knowledge about glaucoma was 8.7%  in CGS, 3.1% in the study 
by Prabhu et al65 and 5.6% in the study by Krishnaiah et al. 
 The awareness with respect to age, gender, religion was not significant 
in the study by Prabhu et al and Tenkir et al.66 
 The literacy status and glaucoma awareness were significantly 
associated in CGS and studies by Krishnaiah et al, Prabhu et al, Tenkir et al 
and Gasch et al.67 
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   AIMS AND OBJECTIVES 
 
 To  study  the  prevalence  of  primary  open  angle  glaucoma  in  
patients  aged  40  and above  attending  Ophthalmology  outpatient  
department in Tirunelveli Medical College Hospital to enable  early  
detection  of  this  silent  vision  killer. 
  To evaluate their awareness and knowledge about glaucoma and 
educate them regarding the disease which will infuse  confidence  in  
glaucoma patients  to  face  life  with  full  knowledge  of  the  disease  and  
follow  up  with  involvement. 
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   MATERIALS  AND  METHODS 
  One hundred patients aged 40 years and above attending 
Ophthalmology  outpatient  department in Tirunelveli Medical College 
Hospital from January 2012 to September 2013 were screened for primary 
open angle glaucoma.  
 Institutional Ethical Committee approval was obtained before starting 
first patient enrolment. A convenient sample size of hundred was considered. 
 The study design was prospective cross-sectional study using random 
sampling. The  study  was  randomized  by  choosing 1 among 10 patients 
using block randomization  technique to prevent selection  bias. By this 
method of using randomised table 100 patients were  chosen  from   1000 
patients. A  written informed  consent  was obtained in the patients 40 
years  and above  and they had their  each  eye  tested  for  the  following 
with  the  available  facilities  in  our  hospital : 
 1. Distant  visual  acuity  using  Snellen's  chart 
 2. Near  vision  using  Times  Roman  near  vision  chart 
 3. Refraction  by  autorefractometer  and  subjective  correction 
 4. Intraocular  measurement  using  
  - Schiotz  indentation   tonometer 
  -Goldmann applanation  tonometer 
  - Non  contact  tonometer 
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 5. Optic  disc  evaluation  using  90 D  lens  in  slit lamp   
 6. Visual  field  analysis - central  300 using  Octopus 300   
 automated perimeter – TOP programme68 
 7. Gonioscopy  using  Zeiss  4  mirror  goniolens 
 A questionnaire was given to these patients to collect information 
regarding patient’s awareness and knowledge about glaucoma. The 
questionnaire was translated in Tamil and back- translated to English. 
Literacy level of all subjects were obtained.  The patients who were able to 
read and write any language were  considered as literates.69 The 
questionnaire was administered prior  to the history and examination 
procedures for glaucoma. Details about previous eye check and attending eye 
camps were also obtained.Patients having heard of glaucoma even before the 
study  were defined as aware and who had some understanding about the 
disease were defined as knowledgeable. 
INCLUSION  CRITERIA Patients  aged  40  and  above   
     Both  males  and  females  
EXCLUSION  CRITERIA Patients  not  willing  for  examination 
     Known  PLHA  patients 
     Patients  with  angle  closure  glaucoma   
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RESULTS 
 Table 1: Demographics of the study population 
 MALE FEMALE 
40-49 5 8 
50-59 14 14 
60-69 23 20 
70-79 13 2 
80-89 1 0 
TOTAL 56 44 
 
 Chart 1 : Demographics of the study population 
    
 The above table1 and chart 1 shows the percentage distribution in the 
study subjects according to their age and sex.There were 56 males and 44 
females. 
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Table 2 : Details of age, sex, vision and intraocular pressure of the 
primary open angle glaucoma patients 
 
S.NO AGE SEX 
VISION RE(mm Hg) LE(mm Hg) 
RE LE S NCT AT S NCT AT 
1 60 F 6/60 6/24 22.4 23 22 12.2 13 12 
2 48 M 6/18 6/24 22.4 25 22 24.4 22 22 
3 65 M 5/60 6/12 12.2 12 10 12.2 12 11 
4 73 M 4/60 4/60 24.4 23 22 26.6 33 26 
5 46 M 6/12 6/9 19.6 13 14 14.6 14 14 
 
  The above table 2 shows the age, sex, vision and intraocular 
 pressure values of the 5 primary open angle glaucoma patients. 
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Table 3 : Details of CDR, PPA and visual field of the primary open 
angle glaucoma patients 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
PATIENT 
CDR 
PPA 
FIELD 
RE LE RE LE 
1 0.6 0.9 + 
Superior arcuate 
scotoma 
Tubular field 
2 0.4 0.4 - 
Paracentral 
scotoma 
Normal 
3 0.9 0.5 + 
Temporal island 
of vision 
Superior 
arcuate 
Scotoma 
4 0.6 0.9 + 
Inferior arcuate 
scotoma 
Tubular field 
5 0.7 0.4 + 
Double arcuate 
scotoma 
Normal 
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Chart 2 : Correlation between cup disc ratio and visual field 
 defect  
  
 The above chart 2 shows a linear relationship between CDR and visual 
 field defects. 
 Table 4: Diabetes and primary open angle glaucoma patients 
 
GLAUCOMA 
+ - 
DIABETICS 3 24 
NON  DIABETICS 2 71 
 
 
  
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Right  /  Left eye
Right  /  Left eye
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Chart 3: Diabetes and primary open angle glaucoma patients 
  
 The above table 4 and chart 3 shows the association between diabetes 
and primary open angle glaucoma. By Fisher’s Exact Probability test, no 
significant association (p =0.120) was  found between the diabetic status 
and the occurrence of POAG. 3 out of 27 diabetics were  diagnosed to have 
POAG. 
Table 5: Diabetic retinopathy among diabetics 
DIABETIC RETINOPATHY 
+ - 
6 21 
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Chart 4: Diabetic retinopathy among diabetics 
 
  
 The above table 5 and chart 4 shows the percentage of diabetic 
retinopathy   among the diabetics. Among the diabetics, 6 out of 27 diabetics 
had diabetic retinopathy . 
Table 6: Primary open angle glaucoma among the hypertensives 
 
 
 
 
 
 
 
 
WITH DIABETIC
RETINOPATHY
WITHOUT DIABETIC
RETINOPATHY
 
GLAUCOMA 
+ - 
HYPERTENSION 
+ 2 19 
- 3 76 
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Chart 5: Primary open angle glaucoma among the hypertensives   
  
 The above table 6 and chart 5 shows the association between 
hypertension and POAG. By Fisher’s Exact Probability test, no significant 
association (p =0.282) was  found between the hypertensive status and the 
occurrence of POAG. There were 21 hypertensive patients. 2 of the 21 
hypertensive patients had POAG. 
Table 7: Comparison of intraocular pressure measured with 
applanation and non contact tonometer in the right eye: 
 
 
 
 
 
0
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80
WITH HYPERTENSION WITHOUT
HYPERTENSION
WITH GLAUCOMA
WITHOUT
GLAUCOMA
 MEAN (mm Hg) SD P 
GAT 14.22 3.37 
0.133 
NCT 14.50 3.38 
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 The above table 7 shows that the mean IOP in right eye was 14.22 + 
3.37 mm Hg with applanation tonometer and 14.50 +3.38 mm Hg with non 
contact tonometer. Using paired sample student’s T test, it was found that 
there was no significant difference (p =0.133) between GAT and NCT in the 
right eye. 
Table 8: Comparison of intraocular pressure measured with 
applanation and Schiotz tonometer in the right eye: 
 
 MEAN (mm Hg ) SD P 
GAT 14.22 3.37 
0.000 
SCHIOTZ 15.41 3.19 
 
 The above table 8 shows that the mean IOP in right eye was 14.22 + 
3.37 mm Hg with applanation tonometer and 15.41+ 3.19 mm Hg with 
Schiotz tonometer. Using paired sample student’s T test, it was found that 
there was a significant difference (p<0.001) between GAT and Schiotz in the 
right eye. 
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Table 9:  Comparison of intraocular pressure measured with 
applanation and non contact tonometer in the left eye: 
 
 MEAN(mm Hg ) SD P 
GAT 13.87 3.35 
0.001 
NCT 14.45 3.56 
  
 The above table 9 shows that the mean IOP in the left eye was 13.87 
+3.35 mm Hg with GAT and 14.45 +3.56 mm Hg with non contact 
tonometer. Using paired sample student’s T test, it was found that there was 
a significant difference ( p 0.001) between GAT and NCT in the left eye. 
Table10:Comparison of intraocular pressure measured with 
applanation and Schiotz tonometer in the left eye: 
 
MEAN(mm 
Hg ) 
SD P 
GAT 13.87 3.35 
0.000 
SCHIOTZ 15.22 3.18 
 
 The above table 10 shows that the mean IOP in the left eye was 13.87 
+3.35mm Hg with GAT and 15.22 + 3.18mmHg with Schiotz. Using paired 
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sample student’s T test, it was found that there was a significant difference 
between  GAT  and Schiotz tonometer (p <0.001). 
Table 11: Mean cup disc ratio in the right eye of normal and primary 
open angle glaucoma patients 
 MEAN SD P 
NORMAL 0.31 0.05 
0.000 
POAG 0.64 0.18 
  
 The above table 11 shows the mean CDR in the right eye of normal 
and primary open angle glaucoma patients. The mean CDR in the right eye 
was 0.31 in the normal patients and 0.64 in the POAG patients. Using 
unpaired t test, it was found that there was a significant difference (p < 0.001 
) between the CDR of glaucomatous and non glaucomatous patients in the 
right eye.   
Table 12: Mean cup disc ratio in the left eye of normal and primary 
open angle glaucoma patients 
 MEAN SD P 
NORMAL 0.32 0.05 
0.000 
POAG 0.62 0.25 
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 The above table 12 shows the mean CDR in the left eye of normal and 
primary open angle glaucoma patients. The mean CDR in the left eye was 
0.32 in the normal patients and 0.62 in the POAG patients. Using unpaired 
 t test, it was found that there was a significant difference (p < 0.001 ) 
between the CDR of glaucomatous and non glaucomatous patients in the left 
eye. 
Table 13: Peripapillary atrophy and primary open angle glaucoma 
 
GLAUCOMA 
+ - 
PERIPAPILLARY 
ATROPHY 
+ 4 2 
- 1 93 
 
Chart 6: Peripapillary atrophy and primary open angle glaucoma 
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 The above table 13 and chart 6 shows the association between 
peripapillary atrophy and POAG. With Fisher’s Exact Probability test with 
Yates continuity correction for small expected numbers, p value was found 
to be <0.001. This means that there is significant association between 
peripapillary atrophy and POAG. Out of the 6 patients who had peripapillary 
atrophy, 4 had POAG. 
Table 14: Severity of glaucomatous damage and glaucoma patients 
 
SEVERITY OF 
DAMAGE 
GLAUCOMA PATIENTS 
NEWLY 
DETECTED 
KNOWN 
MILD 1 0 
MODERATE 1 0 
SEVERE 1 2 
 
Chart 7: Severity of glaucomatous damage and glaucoma patients  
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 The severity of glaucomatous damage is shown in the table 14 and 
chart 7. Among the newly diagnosed  POAG patients, 1 had mild,1 had 
moderate and the other had severe glaucomatous damage. Both the known 
POAG patients had severe glaucomatous damage. 
Table 15: Glaucoma awareness among the patients 
 
GLAUCOMA AWARENESS 
+ - 
GLAUCOMA 
+ 1 4 
- 7 88 
 
Chart 8: Glaucoma awareness among the patients 
    
 The above table 15 and chart 8 shows the glaucoma awareness 
among the patients. With Fisher’s Exact Probability test with Yates 
continuity correction for small expected numbers, p value was found 
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 to be 0.866.This means that there is no significant association between  the 
presence of glaucoma and glaucoma awareness,only 8 were aware of 
glaucoma of which 1 had POAG. 
Table 16: Glaucoma awareness and literacy 
 
GLAUCOMA AWARENESS 
+ - 
 
LITERACY 
+ 6 43 
- 2 49 
  
Chart9 : Glaucoma awareness and literacy 
  
 The above table 16 and chart 9 shows the association between 
glaucoma awareness and literacy. With Fisher’s Exact Probability test, p 
value was found to be 0.122.This means that there is no significant 
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association between literacy and glaucoma awareness.6 out of 49 literates 
and 2 out of  51 illiterates were aware of glaucoma.  
Table 17: Previous  eye check up and primary open angle glaucoma 
 
GLAUCOMA 
+ - 
PREVIOUS 
EYECHECK 
+ 3 68 
- 2 27 
 
Chart 10: Previous  eye check up and primary open angle glaucoma     
  
 The above table 17 and chart 10 shows the association between 
previous eye check up and glaucoma. With Fisher’s Exact Probability test, p 
value was found to be 0.453. It means that there is no significant association 
between POAG and previous eye check . 71 patients had previous ocular 
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examination, of which 3 had POAG. 2 of the primary open angle glaucoma 
patients diagnosed in our study did not have their eyes checked before.  
Table 18: Glaucomatous damage and glaucoma awareness 
 
GLAUCOMA AWARENESS 
+ - 
MILD 0 1 
MODERATE 0 1 
SEVERE 1 2 
 
Chart 11: Glaucomatous damage and glaucoma awareness    
  
 The above table 18 and chart 11 shows the association between 
glaucomatous damage and awareness. With Fisher’s Exact 
Probabilitytest,value was found to be 0.659. This means that there is no 
significant association between the severity of glaucoma and glaucoma 
awareness. 
0
0.5
1
1.5
2
MILD MODERATE SEVERE
WITH GLAUCOMA
AWARENESS
WITHOUT GLAUCOMA
AWARENESS

 
68 
 
    DISCUSSION 
 In our study, 56%  were male and 44% were female. 7.1% of the 
males and 2.2% of the females were diagnosed to have primary open angle 
glaucoma. The high prevalence rate in males was comparable to other 
studies. 
 The overall  prevalence of primary open angle glaucoma was 5%  
which is higher when compared to the South Indian population based 
prevalence study . The reason might be that our study was hospital based. A 
hospital based study by Smita et al in Northern India showed a high 
prevalence of POAG (33% ). The prevalence of glaucoma suspect was 1%. 
 Defective vision was the common presenting complaint in our study 
which is similar to the study by Parikshit et al.70 Among the primary open 
angle glaucoma patients, the visual acuity of  two was significantly affected 
by cataract. Two had presenting  visual acuity  >6/24 and one had decreased 
visual acuity due to posterior capsular opacification.  
 Two of the POAG patients were already diagnosed to have glaucoma. 
Both had severe glaucomatous damage. They were using antiglaucoma 
medications in one eye and combined surgery had been done in the other 
eye. Inspite of this, one had increased IOP. She was followed up. CDR and 
field progression was noted in the eye with medical management. So she 
underwent combined surgery in the other eye also. The other post 
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trabeculectomy  patient did not  show any progression during the follow up 
period. He was continued on medical management in the other eye. Rest of 
the three POAG patients were started on medical treatment. They did not 
show any progression during follow up and had their IOP under control.
 60% of the persons with POAG had not had the disease before our 
study. This is similar to the estimates found in the Visual Impairment Project 
(60%), 51% in Barbados Eye Studies and Blue Mountain Eye Study. In 
contrast to this, the rate of undiagnosed in APEDS was 92.6%, ACES was 
93% and CGS was 98.5%. 
 20% of the newly detected patients had severe glaucomatous damage 
because patients above 40 years of age do not have routine eye check up to 
rule out the possibility of disease in them. 
 In our study, none of the patients had family history of glaucoma. 
Since only few of those with glaucoma are diagnosed and most of them are 
unaware about glaucoma, a family history of no glaucoma may be 
inaccurate. In Rotterrdam study, the first degree relatives of the patients 
diagnosed to have POAG were examined and 22.4% of them were found to 
have POAG. 
 In our study, 11.1% of the diabetics and 2.7% of the non- diabetics  
were found to have POAG. Our study did not show any significant 
association between diabetes and primary open angle glaucoma. The 
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percentage of POAG in diabetics is in excess compared to the VES (4.1%) 
and CGS (0%). 22% of the diabetics had diabetic retinopathy. 
 9.5%. of the POAG patients were hypertensives. Our study did not 
show any significant association between hypertension and POAG. This is 
similar to CGS. A hospital based study by Mohammed et al showed positive 
correlation between POAG and systemic hypertension. 
 IOP found with GAT was comparable with NCT in the right eye but 
there was a significant difference between them in the left eye. There was a 
significant difference between GAT and  Schiotz in both left and right eye. 
However, GAT  is considered as the gold standard.71,72  
 The drawback of our study was that IOP was not corrected for central 
corneal thickness due to the lack of pachymeter in our hospital. 
  In our study, 60% of the patients with POAG presented with an IOP 
>21 mm Hg. This is in contrast to the CGS in which only 32.81% presented 
with increased IOP. The diagnosis of glaucoma cannot be based only on 
increased IOP but increased IOP is an important risk factor. 
 The mean CDR in the right eye was 0.31 in non glaucomatous patients 
and 0.64 in the POAG patients. The mean CDR in the left eye was 0.32 in 
non glaucomatous patients and 0.62 in the POAG patients. There was a 
significant difference between the CDR of glaucomatous and non 
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glaucomatous patients in both eyes. The mean CDR in VES was 0.56 among 
the unselected population group and 0.39 in CGS. 
 There was a significant association between peripapillary atrophy and 
POAG in our study. 6% had peripapillary atrophy, of which 4% had POAG. 
Even though various differential diagnosis can be thought of for 
peripapillary atrophy, it is of prime importance to rule out POAG. The study 
by Kasner et al reported that the absence of peripapillary atrophy is 
associated with decreased risk of glaucomatous damage in ocular 
hypertensives.73 
 In our study, 80% of the primary open angle glaucoma patients had 
their visual field defect corresponding to the optic disc changes. There was a 
significant correlation between visual field defect and CDR. 
 In our study, 8% of the patients were aware of glaucoma. The other 
studies had varying figures.  In spite of combined surgery been done in one 
patient, he was not aware of his disease. 
 In our study, the awareness of glaucoma was comparably low among 
both literates and illiterates. 14% of the literates and 4.1% of the illiterates 
were aware of glaucoma. It was statistically insignificant. This is in contrast  
to CGS and the study by Krishnaiah et al, in which the awareness increased 
exponentially with literacy. Hence education programs targeting the disease 
and its blinding potential must be increased. The aim of education should 
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focus on the benefits of early detection and treatment and changing the 
individual’s perception about glaucoma. 
 Glaucoma awareness among the glaucoma diagnosed patients was also 
low. 
 In our study, 71% had previous eye check up. Among them, 4.2% had 
glaucoma. 33.3% of newly detected primary open angle glaucoma had 
previous eye check up when it was probably missed. The patients who have 
had previous eye check, glaucoma was not diagnosed.  Even though the 
previous eye examination was done by the ophthalmologist, they were not 
detected to have glaucoma prior to our study. This is similar to ACES and 
CGS. An important risk factor for subsequent blindness is late diagnosis of 
glaucoma.  
 In our study, 29% of  the patients did not have their eyes checked up 
in any form, by doctor, optometrist or nurse. 
 Unless optic disc evaluation is done as a routine, we would continue to 
have poor detection rates. According to Thomas et al,74 poor examination 
techniques could also be related to primary training.  Government  eye 
camps should be conducted particularly for screening fundus to rule out 
glaucoma.  
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 The referral sources are an important factor for early diagnosis. Other 
eye care personnel (ophthalmic assistants and optometrists) also must  
contribute.  
 The knowledge  about glaucoma was 0%. 
 Glaucoma causes irreversible blindness and  the affected people are 
unaware of their condition.In our study ,none of them were aware that the 
vision loss due to glaucoma was permanent and irreversible. Hence 
knowledge of glaucoma as a cause of irreversible  blindness is 0%. 
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    CONCLUSION 
1.The overall prevalence of POAG was 5% in our study and the prevalence 
of glaucoma suspect was 1%. 
2.Males had higher prevalence of glaucoma. 
3.Diabetes and hypertension did not have any significant etiological 
association with POAG. 
4.Intraocular pressure was not a definitive risk factor for screening, diagnosis 
and treatment of the patients. 
5.Visual field changes had good correlation with the optic disc changes. 
6.CDR and peripapillary atrophy had good  correlation with POAG. Hence 
fundus examination is mandatory in all patients above 40 years of age. 
7.60% of the glaucoma patients were newly diagnosed, of which 20% had 
severe glaucomatous damage. 
8.Glaucoma awareness was extremely low considering the magnitude of 
blindness due to glaucoma. 
9.There was no significant association between literacy and glaucoma 
awareness. 
10.Previous eye check up and eye camps were not effective in creating 
awareness in the patients. 
11.The knowledge  about glaucoma was 0%. 
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12.In accordance with World Glaucoma Association, World Glaucoma 
Patient Association and Glaucoma Society of India, public, patients and the 
health care personnel should be tuned in both creating awareness and 
diagnosing glaucoma. 
13.The family members of the glaucoma patients must be examined to rule 
out glaucoma. 
14.Ophthalmoscopes should be provided to all ophthalmic assistants. They 
must be trained to look for glaucomatous optic disc cupping and report all 
suspicious optic discs. This would take glaucoma eye care to the rural areas. 
15.Ophthalmologists must be trained to give special attention to  glaucoma. 
16.All eye care personnel should counsel the patients about the irreversible 
blindness caused by glaucoma. 
17.It is high time media based health education focuses on glaucoma. 
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PROFORMA 
Name :                              Age:                  Sex: 
Op No:    Occupation:  Socioeconomic status : 
Address:    Phone number : 
History: 
O  Defective vision      O  Headache           O  Defective night vision     
O  Field loss            O  Coloured halos      `O  Frequent change of glasses 
Past History :  
O   Diabetes     O  Hypertension   O  Myopia       O  COPD / asthma  
O  Trauma       O  Use of steroid eye drops           O  Acute fluid loss       
O  Blood loss during surgery/trauma       O Major surgery   
O  H/O refractive surgery(excimer laser)              O Shock during anaesthesia          
O  Raynaud’s phenomenon/vasospastic episodes   O  Migraine    
O  Self antihypertensives intake without prescription  
Family History : 
  Known glaucoma patient  - First degree relatives/others 
Personal History :  
 O  Smoking                          O  Alcohol consumption         
EXAMINATION : 
Media status :  OD :     OS : 
Distant vision :   OD :  OS : 
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Near vision :   OD :                            OS : 
Refraction : AR :  OD :                                  OS :                    
   Sub:  OD :     OS : 
IOP :     OD      OS 
   Schiotz 
     GAT 
    NCT  
Fundus :    
 1) Disc  - overall size/ cup/ CDR(vertical)/ Asymmetry 
 2) Neuro retinal rim –colour/ thinning/notching 
     acquired optic pit/absence/translucency 
 3) Splinter haemorrhages 
 4) Peripapillary atrophy 
 5) RNFL(red free filter) 
 6) Vessels – Outpassing/Nasalization of vessels  
   Baring of circumlinear vessels/Bayonetting of vessels 
 7) Laminar dots 
 8) Others 
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    OD    OS 
       
Visual field analysis:    OD     OS  
 Overall sensitivity depression 
 Paracentral scotoma  
 Nasal step 
 Arcuate scotoma 
 Ring scotoma 
 Tubular vision 
 Temporal island 
 Others 
Gonioscopy: 
    OD      OS 
   
 
Diagnosis :   
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GLAUCOMA AWARENESS QUESTIONNAIRE 
 
Name    Age    Sex 
Urban / Rural  Literacy  Socioeconomic Status 
1) a) Have you ever heard of glaucoma 
 b) How did you come to know about glaucoma 
 c) Have you seen/heard/read any advertisement or publicity recently about  
 glaucoma 
2) a) What is glaucoma 
 - increase in pressure  
 - damage to nerve due to increased pressure in the eye 
 b) Symptoms of glaucoma  
 - defective vision  
 - pain /watering/redness  
 - other symptoms with good vision 
 c) Risk factors for glaucoma  
 Increased IOP, steroids, smoking, alcohol, family history of 
 glaucoma, diabetes ,hypertension, migraine, myopia/ hypermetropia 
 d) Is glaucoma treatable 
  Therapies for glaucoma – eye drops , laser, surgery 
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  Purpose of treatment 
 - irreversible on Rx 
 -permanent damage 
 -prevent  progression 
3) a) When is the last time you had eye check up 
 b) What is the earliest age you eye check up 
 c) Have you ever checked IOP / field 
4) a) Has the eye doctor who checked you told about glaucoma 
  b) Did the physician tell you about glaucoma 
5) a)  Have you attended any eye camp 
 b) Has anybody told about glaucoma in the eye camp 
6) Do you know that glaucomatous damage is  irreversible 
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ABBREVATIONS USED IN THE MASTER CHART 
M   Male 
F   Female 
CAD   Coronary artery disease 
CVA   Cerebral vascular accident 
COPD  Chronic obstructive pulmonary disease 
BCVA  Best corrected visual acuity  
G   Visual acuity > 6/12 
Mo   Visual acuity 6/18 – 6/60 
P   Visual acuity < 6/60 
PPA   Peripapillary atrophy 
RE   Right eye 
LE   Left eye 
BE   Both eyes 
NCT   Non contact tonometer 
GAT   Goldmann applanation tonometer 
POAG  Primary open angle glaucoma 
NPDR  Non proliferative diabetic retinopathy 
PDR   Proliferative diabetic retinopathy 
HTR   Hypertensive retinopathy 
POST TRAB Post trabeculectomy 
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1 BALA 55 M - - - - - - - G G 17.3 14 16 17.3 12 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
2 HELINA 42 F - - - - - - - G G 14.6 14 14 14.6 17 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
3 VELAMMAL 60 F + - - - - - - P G 14.6 12 14 14.6 12 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
4 SUBALAKSHMI 45 F + + - - - - + Mo Mo 14.6 13 16 14.6 15 16 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
BE POAG
/LE POST TRAB
6 DAISY 65 F + - + - - - - G Mo 13.4 19 18 14.6 19 18 0.4 0.3 - - - - - - IV NO GLAUCOMA + + - -
7 RAMASAMY 70 M + - - - CAD - + P Mo 14.6 14 12 14.6 14 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
8 SHIVARAMAN 65 M + + - - - - + Mo Mo 17.3 19 20 17.3 19 20 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
NO GLAUCOMA
/BE MILD NPDR
10 PAPPAMMAL 56 F + - - - - + P P 12.2 9 10 12.2 8 10 0.4 0.3 - - - - - - IV NO GLAUCOMA - + - -
11 KARUTHAIAH 65 M - - - - - - - Mo G 20.6 20 18 20.6 20 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
12 ANNAPUSHPAM 47 F + - - - - - - P P 14.6 11 10 14.6 11 12 0.4 0.4 - - - - - - IV NO GLAUCOMA - + - -
13 SORIMUTHU 53 M + - - - - - + P P 14.6 8 14 14.6 9 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
14 VALLI 43 F - - - - - - - G G 17.3 15 16 17.3 14 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
15 KRISHNAMMAL 60 F + + - - - - - Mo Mo 12.2 10 10 14.6 12 12 0.4 0.4 - - - - - - IV NO GLAUCOMA - + - -
15 16 0.3- - + Mo Mo 17.3 15 16 17.3 + - -0.3 - - - - - - IV -9 MUTHUMALAI 65 F + + - -
+12 0.6 0.9 - + +Mo 22.4 13+ - - - + Mo + -+ + IV + +5 VALITHANGAM 60 F + +
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16 ABDUL RAHMAN 48 M + + + - CAD - - Mo Mo 22.4 25 22 24.4 22 22 0.4 0.4 - - + - + - IV RE POAG - - - -
17 NAMBIRAJAN 71 M + + - - - - + Mo Mo 10.2 10 10 10.2 11 10 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
18 KANTHAN 67 M + - + - - - + P P 15.9 17 16 20.6 20 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
19 CHINNAMMAL 50 F - - - - - - - G G 17.3 15 16 20.6 17 18 0.2 0.3 - - - - - - IV NO GLAUCOMA - + - -
20 MUTHAIAH 82 M - - - - - - - G G 10.2 11 9 10.2 11 10 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
21 SENDU 70 F - - - - - - - G G 20.6 18 18 17.3 16 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
22 KRISHNASAMY 59 M + - - - - - + G Mo 17.3 15 16 17.3 14 16 0.4 0.4 - - - - - - IV NO GLAUCOMA - + - -
23 SHANMUGAVEL 52 M + + - - - - + P P 14.6 12 10 14.6 11 10 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
24 JANBEGAM 53 F - - - - - - - G G 17.3 16 16 17.3 15 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
25 PERIAMANI 70 F + - - - - - + P Mo 12.2 10 12 12.2 8 10 0.4 0.3 - - - - - - IV NO GLAUCOMA - + - -
26 RANJITHAM 60 F + - - - - - + P P 20.6 14 18 17.3 15 16 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
27 PARVATHY 55 F + - - - - - + Mo Mo 15.9 12 16 17.3 16 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
28 ARUNACHALAM 63 M + - + - - - + G P 12.2 10 8 12.2 10 8 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
29 FATIMA 60 F + - - - - - + G P 20.6 16 18 17.3 15 16 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
30 PHILOMINAL 65 F - - - - - - - G G 14.6 14 12 14.6 13 12 0.3 0.3 - - - - - - IV NO GLAUCOMA + + + -
31 VENKATRAJ 64 M + - - - CVA - + P P 17.3 16 18 17.3 15 16 0.4 0.3 + + - - - - IV NO GLAUCOMA - + - -
32 SUBBIAH 50 M + - - - - - + P P 14.6 13 12 14.6 12 10 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
33 SARASWATHI 65 F + - - - - - + P P 12.2 14 12 12.2 15 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
34 ANNAKILI 55 F + - - - - - + Mo P 14.6 16 14 14.6 16 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
35 PERUMAL 70 M + - - - - - - G P 12.2 15 12 14.6 16 12 0.3 - - - - - - - IV NO GLAUCOMA - + - -
36 THANGARAJ 45 M + - - - - - + Mo Mo 10.2 9 8 8.5 9 8 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
37 REVATHI 43 F + - - - - - + P P 14.6 15 14 14.6 15 14 0.1 0.1 - - - - - - IV NO GLAUCOMA - + - -
38 SARASWATHI 54 F - - - - - - - G G 10.2 11 10 10.2 13 11 0.3 0.4 - - - - - - IV NO GLAUCOMA - + - -
39 ANANDARAJ 70 M + + - - - - + Mo P 12.2 10 12 12.2 11 12 0.4 - - - - - - - IV NO GLAUCOMA - - - -
40 CHELLADURAI 53 M + - + - - - + Mo Mo 14.6 13 12 14.6 16 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
41 KANNAMAL 65 F + - - - - - + P P 17.3 15 14 17.3 15 14 - - - - - - - - IV NO GLAUCOMA - - - -
42 DHANUKODI 60 M - - + - - - - Mo Mo 14.6 15 12 14.6 14 12 0.3 0.3 + + - - - - IV NO GLAUCOMA - - - -
BE POAG
/RE POST TRAB
44 MARIAMMAL 60 F - - - - - - - G Mo 10.2 11 10 10.2 13 11 0.4 0.4 - - - - - - IV NO GLAUCOMA - + - -
45 FLORANCE 50 F - - - - - - - G G 14.6 15 18 14.6 17 16 0.4 0.4 - - - - - - IV NO GLAUCOMA - - - -
+11 0.9 0.5 + + +G 12.2 12- - - - - P43 PERIANDI 65 M + - - -+ + IV - +12 10 12.2
46 AYYASAMY 70 M - - - - - - + P P 17.3 13 14 12.2 12 10 - - - - - - - - IV NO GLAUCOMA - + - -
47 JAYASEELI 62 F - - + - - - - Mo Mo 14.6 11 10 14.6 11 12 0.3 0.2 - - - - - - IV NO GLAUCOMA - + - -
48 THANGAIAH 56 M + + - - - - + P P 12.2 11 8 12.2 11 10 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
49 MAGAMAYI 65 F + - + - - - + Mo Mo 14.6 15 12 14.6 15 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
50 AKBAR 65 M - - - - - - + Mo Mo 14.6 14 12 14.6 13 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
51 MARIAPPAN 66 M + + - - - - + Mo Mo 17.3 19 18 17.3 17 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
52 SASTAKUTTY 70 M - - - - - - + Mo Mo 17.3 18 18 12.2 10 8 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
NO GLAUCOMA
/BE MILD NPDR
54 DAVID 45 M - - - - - - - G G 10.2 12 10 10.2 12 10 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
55 MOHAMMED 73 M + - - + - - + P P 24.4 23 22 26.6 33 26 0.6 0.9 - + + + + + IV BE POAG - + - -
56 SUBBIAH 76 M + + + - - - + P P 20.6 20 18 20.6 20 18 0.3 0.4 - - - - - - IV NO GLAUCOMA - - - -
57 PAULRAJ 67 M - - - + - - - Mo Mo 14.6 13 16 14.6 15 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
58 ISAKIMUTHU 63 M + + + - - - + Mo Mo 17.3 19 16 17.3 18 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
NO GLAUCOMA
/BE PDR
60 KARUTHAN 75 M - - - - - - - Mo P 15.9 14 12 15.9 16 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
61 KANNIAMMAL 42 F + - - - - - + P Mo 20.6 20 18 20.6 20 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
NO GLAUCOMA
/BE HTR
63 KARUPUSAMY 64 M - + + - - - - G G 15 14 16 15 12 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
64 MARIAMMAL 45 F + - - - CAD - + P G 13.4 13 12 13.4 16 14 - 0.3 - - - - - - IV NO GLAUCOMA - + - -
65 UMA 51 F + - - - - - + Mo Mo 20.6 18 16 20.6 17 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
66 SIVAGAMI 65 F - - - - - - - G G 13.4 8 8 13.4 9 8 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
67 JOHNSON 52 M + - + - - - + Mo P 13.4 12 12 13.4 14 12 0.2 0.3 - - - - - - IV NO GLAUCOMA - + - -
68 EASWARI 61 M - + + - - - - G G 17.3 18 16 17.3 17 16 0.3 0.2 - - - - - - IV NO GLAUCOMA - + - -
69 NELLAIVADIVU 68 F + - + - - - + P Mo 14.6 15 14 14.6 15 14 - 0.3 - - - - - - IV NO GLAUCOMA - + - -
70 ABRAHAM 70 M - - - - - - + G P 20.6 19 18 17.3 18 16 0.3 0.4 - - - - - - IV NO GLAUCOMA + + + -
71 CHELLAMMAL 65 F - - - - - - + P P 14.6 15 12 14.6 13 12 0.2 0.2 - - - - - - IV NO GLAUCOMA - - - -
72 SHENBAGAM 57 F - + - - - - - G G 20.6 16 18 20.6 17 18 0.4 0.4 - - - - - - IV NO GLAUCOMA - + - -
73 VELU 66 M - + - - - - - G G 20.6 16 18 20.6 19 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
- IV -14 14 14.6 16 14 0.3- - + Mo P 14.6 + - -0.3 - - - - -62 KADAKARAI 64 M + + + -
-8 0.4 0.4 + + -Mo 17.3 10+ - CAD - + P - -- - IV - +59 VARALAKSHMI 55 F + + 18 18 14.6
- IV +14 14 12.2 10 14 0.4 + + -0.3 - - - - -- - - - - G G 12.253 MUTHU 53 M - +
74 MOHAMED 50 M + - - - - - + P Mo 17.3 17 16 17.3 17 16 - 0.2 - - - - - - IV NO GLAUCOMA + + + -
75 PITCHAIA 60 M - - - + - - - G G 12.2 10 12 12.2 11 12 0.3 0.3 - - - - - - IV NO GLAUCOMA + + - -
76 MAHESHWARAN 49 M - - - - - - - G G 15.9 14 16 13.4 12 12 0.4 0.4 - - - - - - IV NO GLAUCOMA - + - -
NO GLAUCOMA
/BE MOD NPDR
78 LAKSHMI 46 F + - - - - - - Mo Mo 13.4 15 12 13.4 16 14 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
79 CHANDRABOSE 50 M - - - + - - - G G 17.3 16 16 17.3 15 16 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
80 POTTUKANI 60 F - - - - - - - Mo G 14.6 13 14 17.3 18 16 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
GLAUCOMA 
SUSPECT
82 VELTHAI 67 F + - - - - - + P P 17.3 14 16 17.3 16 16 - - - - - - - - IV NO GLAUCOMA - + - -
83 ARUMUGAM 55 M + - + - - - + Mo Mo 14.6 15 16 20.6 18 20 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
84 KARUVELAM 73 M + - - - CKD - + Mo Mo 11.2 14 12 11.2 11 10 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
NO GLAUCOMA/
BE SEVERE NPDR
86 LAKSHMI 60 M - - - - - - - Mo Mo 20.6 19 21 17.3 18 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
87 PUDUMAI 51 F - - - - - - - G G 17.3 18 18 13.4 12 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
88 KANNAN 60 M + - - - - - - Mo Mo 12.2 9 10 12.2 11 10 0.2 0.2 - - - - - - IV NO GLAUCOMA - + - -
89 ISAKIAMMAL 50 F + + + - - - + P P 12.2 11 10 13.4 12 12 0.3 - - - - - - - IV NO GLAUCOMA - + - -
NO GLAUCOMA
/BE MILD NPDR
91 MARIAPPAN 75 M + - - - - - + Mo G 20.6 20 18 20.6 20 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
92 PRABAKARAN 60 M + + + - CAD - + P P 12.2 11 10 12.2 11 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
93 MARIMUTHU 70 M + - - - - - + Mo Mo 12.2 9 12 12.2 11 10 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
94 KANTHAMMAL 65 F + - - + - - + G P 14.6 15 14 14.6 15 14 0.3 - - - - - - - IV NO GLAUCOMA - + - -
95 PONNAMMAL 61 F + - - - - - + Mo Mo 14.6 14 12 12.2 13 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
96 MUTHU 63 M + - - - - - + P Mo 17.3 19 18 17.3 17 18 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
97 VELAYUDAM 46 M - + - - - - - G G 19.6 13 14 14.6 14 14 0.7 0.4 + + + - + - IV RE POAG - - - -
98 SETHALAKSHMI 59 F + + - - - - + Mo P 12.2 13 12 14.6 15 12 0.3 0.3 - - - - - - IV NO GLAUCOMA - - - -
99 SELVARAJ 58 M + - - - - - + Mo P 14.6 15 14 13.4 13 14 0.3 - - - - - - - IV NO GLAUCOMA - + - -
100 THAYAMMAL 55 F + - - - - - + Mo G 10.2 11 10 11.2 13 10 0.3 0.3 - - - - - - IV NO GLAUCOMA - + - -
- - IV - + - -17.3 13 14 0.2 0.5 - - - -- - - + Mo Mo 17.3 15 16
- -- - - IV - -18 0.3 0.3 - - -16 17.3 16+ - - - - G90 PASUPATHY 56 M - +
- IV +15 14 14.6 15 14 0.3- - + Mo Mo 14.6
G 17.3 18
+ + -0.3 - - - - -85 SHIVA 66 M + + - -
-12 0.4 0.4 - - -G 12.2
81 SAMI 65 +M - -
13- - - - - G - -- - IV - +77 CHELAPPA 69 M - + 14 12 12.2
